cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ironwood Pharmaceuticals Inc
2 own
9 watching
Current Price
$11.4
$-0.14
(-1.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,747.84M
52-Week High
52-Week High
12.95
52-Week Low
52-Week Low
9.73
Average Volume
Average Volume
2.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
4.0198
iconMarket Capitalization1,747.84M
icon52-Week High12.95
icon52-Week Low9.73
iconAverage Volume2.28M
iconDividend Yield--
iconP/E Ratio4.0198
What does the Ironwood Pharmaceuticals Inc do?
Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout under ZURAMPIC and DUZALLO names. It has collaboration agreements with Allergan plc and AstraZeneca AB to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other GI conditions in North America, China, Hong Kong, and Macau; and license agreement with Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, chronic constipation, and other GI conditions in Japan. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Ironwood Pharmaceuticals Inc make?
News & Events about Ironwood Pharmaceuticals Inc.
Zolmax
25days ago
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) CEO Thomas A. Mccourt sold 110,962 shares of the companys stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $12.07, for a total transaction of $1,339,311.34. Following the completion of the ...
Ticker Report
25days ago
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) CEO Thomas A. Mccourt sold 110,962 shares of the companys stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $12.07, for a total transaction of $1,339,311.34. Following the completion of...
Zolmax
5 months ago
Blueshift Asset Management LLC reduced its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) by 16.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,354 shares of the biotechnology ...
Zolmax
5 months ago
Aaron Wealth Advisors LLC bought a new stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,648 shares of the ...
Zolmax
8 months ago
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) CEO Thomas A. Mccourt sold 36,308 shares of the firms stock in a transaction on Monday, May 23rd. The stock was sold at an average price of $11.50, for a total value of $417,542.00. Following the completion of the sale, the chief executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Ironwood Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Ironwood Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Ironwood Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ironwood Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What percentage is Ironwood Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ironwood Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.4
$-0.14
(-1.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00